Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-04-18
1990-01-30
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142342, 5142345, 514316, 514322, 544127, 544129, 546118, 546187, 546199, A61K 3144, C07D47104
Patent
active
048974013
ABSTRACT:
Novel N-(4-piperidinyl)bicyclic condensed 2-imidazolamine derivatives and their pharmaceutically acceptable acid addition salts having anti-histaminic properties, compositions containing the same, and methods of treating allergic diseases in warm-blooded animals.
REFERENCES:
patent: 4219559 (1980-08-01), Janssens et al.
patent: 4556660 (1985-12-01), Janssens et al.
patent: 4588722 (1986-05-01), Janssens et al.
patent: 4634704 (1987-01-01), Janssens et al.
patent: 4695569 (1987-09-01), Janssens et al.
Diels Gaston S. M.
Janssens Frans E.
Torremans Joseph L. G.
Dentz Bernard
Janssen Pharmaceutical N.V.
Lee Mary C.
Metz Charles J.
LandOfFree
N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1923598